Compare

Two peptides, one row at a time.

Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.

Peptide A

Abaloparatide (PTHrP analog, Tymlos)

warningBioGate · AMBERGrade B
postmenopausal osteoporosis at high fracture risk (FDA approved)
Peptide B

BPC-157

verifiedBioGate · GREENGrade B
soft-tissue recovery
Identity
  • Sequence≠
    AVSEHQLLHDKGKSIQDLRRRELLEKLLAKLHTA
    GEPPPGKPADDAGLV
  • Length≠
    34 aa
    15 aa
  • Molecular weight≠
    3961.00
    1419.55
  • Modifications≠
    PTHrP-related synthetic 34-residue analog
    acetyl-N-terminus
  • Mechanism

    PTHrP analog with selective PTH1R RG conformation binding; faster anabolic effect with reduced hypercalcemia vs. teriparatide.

    Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.

Provenance
  • BioGate≠
    warningBioGate · AMBER
    verifiedBioGate · GREEN
  • PDA-V1 outer≠
  • Inputs hash≠
  • Model version
    structure-fm-2026.04
    structure-fm-2026.04
  • PDA candidates≠
    2
    4
Outcomes
  • RWE cohorts
    5
    5
  • Total participants≠
    83
    270
  • Primary endpoint Δ≠
    +2.46 Δ HRV ms (8-week)
    95% CI [1.39, 3.53]
    -1.7 Δ HRV ms (8-week)
    95% CI [-2.46, -0.94]
  • LOO posterior≠
    40.8%
    β(13.9, 20.1)
    88.1%
    β(33.8, 4.6)
  • Top-grade citations≠
    Grade B1 of 1
    Grade B2 of 2
Economics
  • IPNFT≠
    Molecule IPNFT V2
    Solana · 267 holders
    Molecule IPNFT V2
    Solana · 73 holders
  • Royalty cascade≠
    3.90%
    10.04%
Indications
  • Listed indications≠
    • · postmenopausal osteoporosis at high fracture risk (FDA approved)
    • · soft-tissue recovery
    • · GI mucosal repair
    • · tendon healing